Jefferson County Nears 23K Vaccine Doses Administered; More than 4.3M Doses Given Statewide

JEFFERSON CO., Pa. (EYT) – Pennsylvania has administered 4,483,724 COVID-19 vaccines, with Jefferson County receiving 22,681 doses, according to state data.

The numbers do not include federal facilities or Philadelphia, which track their information separately.

The state’s vaccine dashboard allows residents to track the progress of the vaccine by county. It breaks the data down by people who are fully vaccinated and those who are awaiting their second dose.

The following statistics are for the week ending Friday, March 27.

Jefferson County (Population 43,425)
Total: 22,681
Full: 9,890
Partial: 12,791

Clarion County (Population: 38,438)
Total: 16,984
Full: 7,151
Partial: 9,833

Forest County (Population 7,247)
Total: 2,973
Full: 1,272
Partial: 1,701

Venango County (Population 50,668)
Total: 15,387
Full: 6,346
Partial: 9,041

Coronavirus in Pennsylvania

Pennsylvania tracked 1,005,167 positive and probable cases of COVID-19 since the beginning of the pandemic more than a year ago. 91% of Pennsylvanians have recovered, but 24,986 did not. Clarion County recorded 2,820 cases with 88 deaths. Forest County’s 1392 cases resulted in 21 deaths. Jefferson County had 2,960 cases with 91 deaths. In Venango County, the total number of cases is 3,559 with 90 deaths.

The vaccines currently in Pennsylvania are manufactured by Moderna, Pfizer, and Johnson & Johnson. If a resident has received their first dose of the Pfizer or Moderna vaccines, they should return to the same provider for their second dose.

For more information on how vaccines are tested and determined to be safe, visit the CDC’s vaccine development website.

Pennsylvania is currently in Phase 1A of its vaccine rollout. Phase 1A covers long-term care facility residents, healthcare workers, people over 65, and people between the ages of 16-64 with high-risk conditions. Check your eligibility through the state’s tool here.

Copyright © 2021 EYT Media Group, Inc. All rights reserved. Any copying, redistribution or retransmission of the contents of this service without the express written consent of EYT Media Group, Inc. is expressly prohibited.

Comments are temporarily closed. A new and improved comments section will be added soon.